Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes

  • Technology appraisal guidance
  • TA390
  • Published: 

Tools and resources

Tools and resources to help you put the guidance into practice.

Guidance into practice